Monroe Capital Supports Linden Capital Partners’ Acquisition of ProPharma Group
Chicago, IL, October 6, 2016
Monroe Capital LLC today announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group (“ProPharma”) by private equity sponsor, Linden Capital Partners.
Founded in 2001 and based in Overland Park, Kansas, ProPharma is a leading provider of outsourced medical information, pharmacovigilance, and regulatory compliance consulting services to customers in the pharmaceutical, biotechnology, and medical device industries. The company has grown to a global organization operating five contact centers across the United States, Europe and Australia. ProPharma serves a customer base which includes many of the world’s largest and well-known biopharmaceutical companies.
About Monroe Capital
Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, asset based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital prides itself on its flexible investment approach and its ability to close and fund transactions quickly. Monroe is committed to being a value-added and user-friendly partner to owners, senior management and private equity sponsors. Monroe has been recognized by Global M&A Network as the 2015, 2014, and 2013 Small Middle Markets Lender of the Year; Private Debt Investor as the 2015 Lower Mid-Market Lender of the Year, the 2014 Senior Lender of the Year, and the 2013 Unitranche Lender of the Year; and the U.S. Small Business Administration as the 2015 Small Business Investment Company (SBIC) of the Year. To learn more about Monroe Capital LLC, visit www.monroecap.com.